--- 
layout: page 
image:
  feature: DaubEnginePatent.jpg
--- 
   <head>
      <title>2731-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-2700.html"><span>Chapter 2700</span></a></li>
      <li><span>Section 2731</span></li>  </ul>  </div>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="d0e273655">
                     <h1 class="page-title">2731
                        &nbsp;&nbsp;
                        Period of Adjustment [R-11.2013]
                     </h1>
                     <div id="d0e273662" class="CFR">
                        <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.703 &nbsp;
                              
                              
                              
                              Period of adjustment of patent term due to examination
                              delay.</i></h4>
                        <ul style="list-style-type: none;">
                           <li id="d0e273667" class="nobull">(a)  The period of adjustment
                              under <b><a href="mpep-9020-appx-r.html#d0e331127">§ 1.702(a)</a></b> is the sum of
                              the following periods: 
                              <ul style="list-style-type: none;">
                                 <li id="" class="nobull">
                                    <p id=""></p>
                                 </li>
                                 <li id="d0e273674" class="nobull">(1) The number of days,
                                    if any, in the period beginning on the day after the date that is
                                    fourteen months after the date on which the application was filed under
                                    <b><a href="mpep-9015-appx-l.html#d0e302673">35 U.S.C. 111(a)</a></b> or
                                    the date the national stage commenced under <b><a href="mpep-9015-appx-l.html#d0e307173">35 U.S.C.
                                          371(b)</a></b> or <b><a href="mpep-9015-appx-l.html#d0e307239">(f)</a></b>
                                    in an international application and ending on the date of mailing of
                                    either an action under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C.
                                          132</a></b>, or a notice of allowance under
                                    <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C. 151</a></b>,
                                    whichever occurs first;
                                 </li>
                                 <li id="d0e273690" class="nobull">(2) The number of days,
                                    if any, in the period beginning on the day after the date that is four
                                    months after the date a reply under <b><a href="mpep-9020-appx-r.html#d0e322449">§
                                          1.111</a></b> was filed and ending on the date of mailing
                                    of either an action under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b>, or a
                                    notice of allowance under <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C. 151</a></b>,
                                    whichever occurs first;
                                 </li>
                                 <li id="d0e273706" class="nobull">(3) The number of days,
                                    if any, in the period beginning on the day after the date that is four
                                    months after the date a reply in compliance with <b><a href="mpep-9020-appx-r.html#d0e322575">§
                                          1.113(c)</a></b> was filed and ending on the date of
                                    mailing of either an action under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C.
                                          132</a></b>, or a notice of allowance under
                                    <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C. 151</a></b>,
                                    whichever occurs first;
                                 </li>
                                 <li id="d0e273719" class="nobull">(4) The number of days,
                                    if any, in the period beginning on the day after the date that is four
                                    months&nbsp;after the date an appeal brief in compliance with
                                    <b><a href="mpep-9020-appx-r.html#d0e356598">§
                                          41.37</a></b> was filed and ending on the date of mailing
                                    of any of an examiner’s answer under <b><a href="mpep-9020-appx-r.html#d0e356741">§ 41.39</a></b>, an action
                                    under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b>, or a
                                    notice of allowance under <b><a href="mpep-9015-appx-l.html#d0e303440">35&nbsp;U.S.C.
                                          151</a></b>, whichever occurs first;
                                 </li>
                                 <li id="d0e273735" class="nobull">(5) The number of days,
                                    if any, in the period beginning on the day after the date that is four
                                    months after the date of a final decision by the Patent Trial and Appeal
                                    Board or by a Federal court in an appeal under <b><a href="mpep-9015-appx-l.html#d0e303314">35
                                          U.S.C. 141</a></b> or a civil action under
                                    <b><a href="mpep-9015-appx-l.html#d0e303379">35 U.S.C. 145</a></b> or
                                    <b><a href="mpep-9015-appx-l.html#d0e303393">146</a></b> where at least
                                    one allowable claim remains in the application and ending on the date of
                                    mailing of either an action under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C.
                                          132</a></b> or a notice of allowance under
                                    <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C. 151</a></b>,
                                    whichever occurs first; and
                                 </li>
                                 <li id="d0e273754" class="nobull">(6) The number of days,
                                    if any, in the period beginning on the day after the date that is four
                                    months after the date the issue fee was paid and all outstanding
                                    requirements were satisfied and ending on the date a patent was
                                    issued.
                                 </li>
                              </ul>
                           </li>
                           <li id="d0e273758" class="nobull">(b)  The period of adjustment
                              under <b><a href="mpep-9020-appx-r.html#d0e331127">§ 1.702(b)</a></b> is the number of
                              days, if any, in the period beginning on the day after the date that is three
                              years after the date on which the application was filed under <b><a href="mpep-9015-appx-l.html#d0e302673">35&nbsp;U.S.C.
                                    111(a)</a></b> or the national stage commenced under
                              <b><a href="mpep-9015-appx-l.html#d0e307164">35&nbsp;U.S.C. 371(b) or (f)</a></b> in
                              an international application and ending on the date a patent was issued, but
                              not including the sum of the following periods:
                              <ul style="list-style-type: none;">
                                 <li id="" class="nobull">
                                    <p id=""></p>
                                 </li>
                                 <li id="d0e273771" class="nobull">(1)  The number of days,
                                    if any, in the period beginning on the date on which a request for
                                    continued examination of the application under <b><a href="mpep-9015-appx-l.html#d0e303187">35
                                          U.S.C. 132(b)</a></b> was filed and ending on the date the
                                    patent was issued;
                                 </li>
                                 <li id="d0e273778" class="nobull">(2)
                                    <ul style="list-style-type: none;">
                                       <li id="d0e273779" class="nobull">(i) The number of
                                          days, if any, in the period beginning on the date an interference
                                          or derivation proceeding was instituted to involve the application
                                          in the interference or derivation proceeding under
                                          <b><a href="mpep-9015-appx-l.html#al_d1d85b_2bf31_106">35 U.S.C.
                                                135(a)</a></b> and ending on the date that the
                                          interference or derivation proceeding was terminated with respect
                                          to the application; and
                                       </li>
                                       <li id="d0e273783" class="nobull">(ii) The number of
                                          days, if any, in the&nbsp;period beginning on the date prosecution in
                                          the application was suspended by the Office due to interference or
                                          derivation proceedings under <b><a href="mpep-9015-appx-l.html#al_d1d85b_2bf31_106">35
                                                U.S.C. 135(a)</a></b> not involving the application
                                          and ending on the date of the termination of the suspension;
                                          
                                       </li>
                                    </ul>
                                 </li>
                                 <li id="d0e273790" class="nobull">(3)
                                    <ul style="list-style-type: none;">
                                       <li id="d0e273791" class="nobull">(i) The number of
                                          days, if any, the application was maintained in a sealed condition
                                          under <b><a href="mpep-9015-appx-l.html#d0e304551">35&nbsp;U.S.C.
                                                181</a></b>;
                                       </li>
                                       <li id="d0e273798" class="nobull">(ii) The number of
                                          days, if any, in the period beginning on the date of mailing of an
                                          examiner's answer under <b><a href="mpep-9020-appx-r.html#d0e356741">§ 41.39</a></b> in the
                                          application under secrecy order and ending on the date the secrecy
                                          order was removed;
                                       </li>
                                       <li id="d0e273805" class="nobull">(iii) The number of
                                          days, if any, in the period beginning on the date applicant was
                                          notified that an interference or derivation proceeding under
                                          <b><a href="mpep-9015-appx-l.html#al_d1d85b_2bf31_106">35 U.S.C.
                                                135(a)</a></b> would be instituted but for the
                                          secrecy order and ending on the date the secrecy order was removed;
                                          and
                                       </li>
                                       <li id="d0e273809" class="nobull">(iv) The number of
                                          days, if any, in the period beginning on the date of notification
                                          under <b><a href="mpep-9020-appx-r.html#d0e337205">§ 5.3(c)</a></b> of
                                          this chapter and ending on the date of mailing of the notice of
                                          allowance under <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C.
                                                151</a></b>; and, 
                                       </li>
                                    </ul>
                                 </li>
                                 <li id="d0e273819" class="nobull">(4) The number of days,
                                    if any, in the period beginning on the date on which jurisdiction over
                                    the application passes to the Patent Trial and Appeal Board under
                                    <b><a href="mpep-9020-appx-r.html#d0e356583">§ 41.35(a)</a></b> of this
                                    chapter and ending on the date that jurisdiction by the Patent Trial and
                                    Appeal Board ends under <b><a href="mpep-9020-appx-r.html#d0e356587">§ 41.35(b)</a></b> of this
                                    chapter or the date of the last decision by a Federal court in an appeal
                                    under <b><a href="mpep-9015-appx-l.html#d0e303314912">35 U.S.C. 141</a></b> or
                                    civil action under <b><a href="mpep-9015-appx-l.html#d0e303379313">35 U.S.C. 145</a></b>,
                                    whichever is later.
                                 </li>
                              </ul>
                           </li>
                           <li id="d0e273841" class="nobull">(c) The period of adjustment
                              under <b><a href="mpep-9020-appx-r.html#d0e331127">§ 1.702(c)</a></b> is the sum of
                              the following periods, to the extent that the periods are not
                              overlapping:
                              <ul style="list-style-type: none;">
                                 <li id="" class="nobull">
                                    <p id=""></p>
                                 </li>
                                 <li id="d0e273848" class="nobull">(1) The number of days,
                                    if any, in the period beginning on the date an interference or proceeding
                                    was instituted to involve the application in the interference or
                                    derivation proceeding under <b><a href="mpep-9015-appx-l.html#d0e303239">35 U.S.C.
                                          135(a)</a></b> and ending on the date that the interference
                                    or derivation proceeding was terminated with respect to the application;
                                    and 
                                 </li>
                                 <li id="d0e273852" class="nobull">(2) The number of days,
                                    if any, in the period beginning on the date prosecution in the
                                    application was suspended by the Office due to interference or derivation
                                    proceedings under <b><a href="mpep-9015-appx-l.html#d0e303239">35 U.S.C. 135(a)</a></b> not
                                    involving the application and ending on the date of the termination of
                                    the suspension.
                                 </li>
                              </ul>
                           </li>
                           <li id="d0e273859" class="nobull">(d) The period of adjustment
                              under <b><a href="mpep-9020-appx-r.html#d0e331127">§ 1.702(d</a></b>) is the sum of
                              the following periods, to the extent that the periods are not overlapping: 
                              <ul style="list-style-type: none;">
                                 <li id="" class="nobull">
                                    <p id=""></p>
                                 </li>
                                 <li id="d0e273866" class="nobull">(1) The number of days,
                                    if any, the application was maintained in a sealed condition under
                                    <b><a href="mpep-9015-appx-l.html#d0e304551">35&nbsp;U.S.C. 181</a></b>;
                                    
                                 </li>
                                 <li id="d0e273873" class="nobull">(2) The number of days,
                                    if any, in the period beginning on the date of mailing of an examiner’s
                                    answer under <b><a href="mpep-9020-appx-r.html#d0e356741">§ 41.39</a></b> of this title
                                    in the application under secrecy order and ending on the date the secrecy
                                    order was removed; 
                                 </li>
                                 <li id="d0e273880" class="nobull">(3) The number of days,
                                    if any, in the period beginning on the date applicant was notified that
                                    an interference or derivation proceeding would be instituted but for the
                                    secrecy order and ending on the date the secrecy order was removed;
                                    and
                                 </li>
                                 <li id="d0e273884" class="nobull">(4) The number of days,
                                    if any, in the period beginning on the date of notification under
                                    <b><a href="mpep-9020-appx-r.html#d0e337205">§ 5.3(c)</a></b> of this
                                    chapter and ending on the date of mailing of the notice of allowance
                                    under <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C.
                                          151</a></b>.
                                 </li>
                              </ul>
                           </li>
                           <li id="d0e273894" class="nobull">(e) The period of adjustment
                              under <b><a href="mpep-9020-appx-r.html#eff_20130401_d0e331268">§ 1.702(e)</a></b> is the sum of
                              the number of days, if any, in the period beginning on the date on which
                              jurisdiction over the application passes to the Patent Trial and Appeal Board
                              under <b><a href="mpep-9020-appx-r.html#d0e356583">§
                                    41.35(a)</a></b> of this chapter and ending on the date of a
                              final decision in favor of applicant by the Patent Trial and Appeal Board or a
                              Federal court in an appeal under <b><a href="mpep-9015-appx-l.html#d0e303314912">35 U.S.C. 141</a></b> or a civil
                              action under <b><a href="mpep-9015-appx-l.html#d0e303379313">35 U.S.C.
                                    145</a></b>.
                           </li>
                           <li id="d0e273913" class="nobull">(f) The adjustment will run
                              from the expiration date of the patent as set forth in <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                                    154(a)(2)</a></b>. To the extent that periods of delay
                              attributable to the grounds specified in <b><a href="mpep-9020-appx-r.html#d0e331127">§ 1.702</a></b>
                              overlap, the period of adjustment granted under this section shall not exceed
                              the actual number of days the issuance of the patent was delayed. The term of a
                              patent entitled to adjustment under <b><a href="mpep-9020-appx-r.html#d0e331127">§ 1.702</a></b>
                              and this section shall be adjusted for the sum of the periods calculated under
                              paragraphs (a) through (e) of this section, to the extent that such periods are
                              not overlapping, less the sum of the periods calculated under <b><a href="mpep-9020-appx-r.html#d0e331597">§
                                    1.704</a></b>. The date indicated on any certificate of mailing
                              or transmission under <b><a href="mpep-9020-appx-r.html#d0e313726">§ 1.8</a></b> shall not be taken
                              into account in this calculation.
                           </li>
                           <li id="d0e273932" class="nobull">(g) No patent, the term of
                              which has been disclaimed beyond a specified date, shall be adjusted under
                              <b><a href="mpep-9020-appx-r.html#d0e331127">§ 1.702</a></b> and this section
                              beyond the expiration date specified in the disclaimer.
                           </li>
                        </ul>
                     </div>
                     <p id="d0e273939"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703</a></b> specifies the period of adjustment if a patent is entitled to
                        patent term adjustment under <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C. 154(b)(1)</a></b> and
                        <b><a href="mpep-9020-appx-r.html#d0e331127">37
                              CFR 1.702</a></b>. When a period is indicated (in <b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703</a></b> or <b><a href="mpep-9020-appx-r.html#d0e331597">1.704</a></b>) as “beginning” on a particular
                        day, that day is included in the period, in that such day is “day one” of the period and
                        not “day zero.” For example, a period beginning on April 1 and ending on April 10 is ten
                        (and not nine) days in length.
                     </p>
                     <p id="d0e273957"><b><a href="mpep-9015-appx-l.html#d0e303482">35
                              U.S.C. 154(b)(1)(A) and (B)</a></b> provide for an adjustment of one day for
                        each day after the end of the period set forth in <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C. 154(b)(1)(A)(i), (ii), (iii),
                              (iv), and (B)</a></b> until the prescribed action is taken, whereas
                        <b><a href="mpep-9015-appx-l.html#d0e303482">35
                              U.S.C. 154(b)(1)(C)</a></b> provides for an adjustment of one day for each
                        day of the pendency of the proceeding, order, or review prescribed in <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(C)(i) through (iii)</a></b>. Therefore, the end of the period set
                        forth in <b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR 1.703(a)</a></b> and <b><a href="mpep-9020-appx-r.html#d0e331320">1.703(b)</a></b> (which
                        correspond to <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C. 154(b)(1)(A) and (B)</a></b>) is “day
                        zero” (not “day one”) as to the period of adjustment, whereas the first day of the
                        proceeding, order, or review set forth in <b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR 1.703(c)</a></b>,
                        <b><a href="mpep-9020-appx-r.html#d0e331320">1.703(d)</a></b>, and <b><a href="mpep-9020-appx-r.html#d0e331320">1.703(e)</a></b> (which correspond to
                        <b><a href="mpep-9015-appx-l.html#d0e303482">35
                              U.S.C. 154(b)(1)(C)(i) through (iii)</a></b>) is “day one” of the period of
                        adjustment.
                     </p>
                     <p id="d0e273993"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(a)</a></b> pertains to <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C. 154(b)(1)(A)</a></b>
                        and indicates that the period of adjustment under <b><a href="mpep-9020-appx-r.html#d0e331127">37 CFR 1.702(a)</a></b> is the
                        sum of the periods specified in <b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR 1.703(a)(1)</a></b> through
                        <b><a href="mpep-9020-appx-r.html#d0e331320">37
                              CFR 1.703(a)(6)</a></b>.
                     </p>
                     <p id="d0e274011"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(a)(1)</a></b> pertains to the provisions of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(A)(i)</a></b> and specifies that the period is the number of days,
                        if any, beginning on the date after the day that is fourteen months after the date on which
                        the application was filed under <b><a href="mpep-9015-appx-l.html#d0e302673">35 U.S.C. 111(a)</a></b> or fulfilled the
                        requirements of <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b> in an international
                        application and ending on the mailing date of either an action under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C.
                              132</a></b>, or a notice of allowance under <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C.
                              151</a></b>, whichever occurs first. For purposes of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(A)(i)(II)</a></b> in effect prior to enactment of the AIA Technical
                        Corrections Act, an international application fulfills the requirements of
                        <b><a href="mpep-9015-appx-l.html#d0e307164">35
                              U.S.C. 371</a></b> on the date of commencement of the national stage under
                        <b><a href="mpep-9015-appx-l.html#d0e307164">35
                              U.S.C. 371(b) or (f)</a></b>, or the date the application fulfills the
                        requirements of <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371(c)</a></b> if that date is later
                        than the date of commencement of the national stage under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371(b) or
                              (f)</a></b>. In other words, the requirements of <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C.
                              371</a></b> are met when applicant has met all of the requirements of
                        <b><a href="mpep-9015-appx-l.html#d0e307164">35
                              U.S.C. 371(c)</a></b> and, unless applicant requests early processing under
                        <b><a href="mpep-9015-appx-l.html#d0e307164">35
                              U.S.C. 371(f)</a></b>, the time limit set forth in the applicable one of
                        <b><a href="mpep-9025-appx-t.html#d0e363665">PCT
                              Articles 22</a></b> and <b><a href="mpep-9025-appx-t.html#d0e364336">39</a></b> has expired. Accordingly, the
                        requirements of <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b> are met when the Office
                        can begin examination of the patent application. If, for example, an applicant files the
                        required oath or declaration (<b><a href="mpep-9015-appx-l.html#d0e302875">35 U.S.C. 115</a></b>) and any necessary
                        English translation <span class="Underline">after</span> the expiration of the
                        time limit set forth in <b><a href="mpep-9025-appx-t.html#d0e363665">Article 22</a></b> of the PCT or the time limit
                        under <b><a href="mpep-9025-appx-t.html#d0e364336">Article 39</a></b> of the PCT, the date the requirements of
                        <b><a href="mpep-9015-appx-l.html#d0e307164">35
                              U.S.C. 371</a></b> are met is the date the requirements of <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C.
                              371(c)</a></b> are met. If, however, an applicant files the required
                        declaration, filing fee, and any required English translation <span class="Underline">before</span> the expiration of the relevant <b><a href="mpep-9025-appx-t.html#d0e363665">PCT Article 22</a></b> or
                        <b><a href="mpep-9025-appx-t.html#d0e364336">Article 39</a></b> time period, but does not request early processing under
                        <b><a href="mpep-9015-appx-l.html#d0e307164">35
                              U.S.C. 371</a></b>, the requirements of <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b> will be
                        met once the applicable time period has expired.
                     </p>
                     <p id="ch2700_d1ff72_1ae8f_164">For patents issuing from international
                        application that are granted on or after January 14, 2013, <b><a href="mpep-9020-appx-r.html#eff_20130401_d0e331335">37 CFR
                              1.703(a)(1)</a></b> in effect on April 1, 2013 applies. The AIA Technical
                        Corrections Act and the changes to <b><a href="mpep-9020-appx-r.html#eff_20130401_d0e331335">37 CFR 1.703(a)(1)</a></b> revised the date
                        that begins the fourteen-month measurement from the date on which the international
                        application fulfilled the requirements of <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b> to the date of
                        commencement of the national stage under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b>. The change to
                        <b><a href="mpep-9015-appx-l.html#d0e303554">35 U.S.C.
                              154(b)(1)(A)(i)(II)</a></b> means that the time period will begin sooner in
                        international applications where the inventor does not file the inventor’s oath or
                        declaration (<b><a href="mpep-9015-appx-l.html#d0e307205">35
                              U.S.C. 371(c)(4)</a></b>) or other requirements at the time of the
                        commencement.
                     </p>
                     <p id="d0e274098"> A written restriction requirement, a
                        written election of species requirement, a requirement for information under
                        <b><a href="mpep-9020-appx-r.html#d0e322262">37
                              CFR 1.105</a></b>, an action under <i>Ex parte
                           Quayle</i>, 1935 Comm’r Dec. 11 (1935), and a notice of allowability (PTOL-37) are
                        each an action issued as a result of the examination conducted pursuant to
                        <b><a href="mpep-9015-appx-l.html#d0e303176">35
                              U.S.C. 131</a></b>. As such, each of these Office actions is a notification
                        under <b><a href="mpep-9015-appx-l.html#d0e303187">35
                              U.S.C. 132</a></b>. Office notices and letters issued as part of the
                        pre-examination processing of an application are not notices issued as a result of an
                        examination conducted pursuant to <b><a href="mpep-9015-appx-l.html#d0e303176">35 U.S.C. 131</a></b>, and thus are not
                        notifications under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b>. Examples of such
                        pre-examination processing notices are: a Notice of Incomplete Nonprovisional Application,
                        a Notice of Omitted Item(s) in a Nonprovisional Application, a Notice to File Missing Parts
                        of Application, a Notice of Informal Application, a Notice to File Corrected Application
                        Papers Filing Date Granted, or a Notice to Comply with Requirements for Patent Applications
                        Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures. 
                     </p>
                     <p id="ch2700_d1ff72_1afdf_294">Written restriction requirements are
                        notifications under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b>. In considering whether a
                        restriction requirement under <b><a href="mpep-9015-appx-l.html#d0e303040912">35 U.S.C. 121</a></b> was appealable under
                        <b><a href="mpep-9015-appx-l.html#d0e303218912313">35 U.S.C.
                              134</a></b>, the Court of Customs and Patent Appeals (CCPA) noted that: (1)
                        <b><a href="mpep-9015-appx-l.html#d0e303040912">35 U.S.C.
                              121</a></b> denoted its restriction procedure as a‘‘requirement’’; (2)
                        <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C.
                              132</a></b> stated that the Commissioner shall give notice to the applicant
                        whenever ‘‘any claim for a patent is rejected, or any objection or requirement made’’; and
                        (3) <b><a href="mpep-9015-appx-l.html#d0e303218912313">35
                              U.S.C. 134</a></b> provided for an appeal only by an applicant whose claims
                        have been‘‘twice rejected.’’ See <i>In re Hengehold</i>, 440 F.2d 1395,
                        1402–03, 169 USPQ 473,479 (CCPA 1971). Thus, the CCPA concluded that Congress intended to
                        differentiate between objections and requirements (<b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b>) and
                        actual rejections of claims (<b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b>) and made appeal
                        applicable only to the latter. See <i>Hengehold</i>, 440 F.2d at 1403, 169 USPQ
                        at 479. Since the CCPA cited with approval the "requirement" language of <b><a href="mpep-9015-appx-l.html#d0e303040912">35 U.S.C. 121</a></b> and
                        evaluated rejections, objections, and requirements together under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b> when
                        discussing and differentiating among them to determine whether a restriction requirement
                        was appealable under <b><a href="mpep-9015-appx-l.html#d0e303218912313">35 U.S.C. 134</a></b>, the CCPA must have
                        considered a restriction requirement to be a requirement under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b>. In
                        other words, the CCPA’s analysis determined that the making of a written restriction (or
                        election) requirement is a notification under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b>. See also
                        <i>Digital Equipment Corp. v. Diamond</i>, 653 F.2d 701, 713 n.13, 210 USPQ
                        521, 535–36 n.13 (1st Cir. 1981) (<b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b> when noting that the
                        terms ‘‘requirement’’ and ‘‘objection’’ are distinct from ‘‘rejection’’ and as such,
                        objections were not appealable under <b><a href="mpep-9015-appx-l.html#d0e303218912313">35 U.S.C. 134</a></b>). In addition, the Office
                        has long considered a written restriction requirement containing no action on the merits to
                        be a notice under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b>. For example, <b><a href="s710.html#d0e79811">MPEP § 710.02(b)</a></b>
                        instructs examiners to set a shortened statutory period for reply of one month for a
                        written restriction requirement containing no action on the merits under the authority
                        given by <b><a href="mpep-9015-appx-l.html#d0e303207aia">35
                              U.S.C. 133</a></b>. <b><a href="mpep-9015-appx-l.html#d0e303207aia">35 U.S.C. 133</a></b> would not apply to the
                        period for reply to a written restriction requirement, if a written restriction requirement
                        containing no action on the merits is not a notice under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b>. 
                     </p>
                     <p id="d0e274119"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(a)(2)</a></b> pertains to the provisions of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(A)(ii)</a></b> and specifies that the period is the number of days,
                        if any, beginning on the day after the date that is four months after the date a reply
                        under <b><a href="mpep-9020-appx-r.html#d0e322449">37
                              CFR 1.111</a></b> was filed and ending on the mailing date of either an
                        action under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b>, or a notice of allowance
                        under <b><a href="mpep-9015-appx-l.html#d0e303440">35
                              U.S.C. 151</a></b>, whichever occurs first.
                     </p>
                     <p id="d0e274137"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(a)(3)</a></b> also pertains to the provisions of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(A)(ii)</a></b> and specifies that the period is the number of days,
                        if any, beginning on the day after the date that is four months after the date a reply in
                        compliance with <b><a href="mpep-9020-appx-r.html#d0e322575">37 CFR 1.113(c)</a></b> was filed and ending on
                        the date of mailing of either an action under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b>, or a
                        notice of allowance under <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C. 151</a></b>, whichever occurs first.
                        A reply under <b><a href="mpep-9020-appx-r.html#d0e322575">37 CFR 1.113 </a></b>is a reply to a final
                        Office action, and a reply in compliance with <b><a href="mpep-9020-appx-r.html#d0e322575">37 CFR 1.113</a></b> is a
                        reply that cancels all of the rejected claims and removes all outstanding objections and
                        requirements or otherwise places the application in condition for allowance. Any amendment
                        after final that does not cancel all of the rejected claims and remove all outstanding
                        objections and requirements or otherwise place the application in condition for allowance
                        is not a reply in compliance with <b><a href="mpep-9020-appx-r.html#d0e322575">37 CFR 1.113(c)</a></b> and will not trigger
                        the four-month requirement under <b><a href="mpep-9020-appx-r.html#eff_20130401_d0e331364">37 CFR 1.703(a)(3)</a></b> for the Office to
                        act on the after-final reply.
                     </p>
                     <p id="d0e274164"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(a)(4)</a></b> also pertains to the provisions of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(A)(ii)</a></b> and specifies that the period is the number of days,
                        if any, beginning on the day after the date that is four months after the date an appeal
                        brief in compliance with <b><a href="mpep-9020-appx-r.html#d0e356598">37 CFR 41.37</a></b> was filed and ending on
                        the mailing date of any of an examiner’s answer under <b><a href="mpep-9020-appx-r.html#d0e356741">37 CFR 41.39</a></b>, an
                        action under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C. 132</a></b>, or a notice of allowance
                        under <b><a href="mpep-9015-appx-l.html#d0e303440">35
                              U.S.C. 151</a></b>, whichever occurs first. As discussed below, the phrase
                        “the date on which” an “appeal was taken” in <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(A)(ii)</a></b> means the date on which an appeal brief (and not a
                        notice of appeal) was filed. The phrase “appeal brief in compliance with <b><a href="mpep-9020-appx-r.html#d0e356598">37 CFR 41.37</a></b>”
                        requires that: (1) the appeal brief fee (<b><a href="mpep-9020-appx-r.html#eff_20130320_d0e315309">37 CFR 1.17(b)</a></b>) be paid
                        (<b><a href="mpep-9020-appx-r.html#d0e356279">37 CFR
                              41.20</a></b>); and (2) the appeal brief complies with the requirements in
                        <b><a href="mpep-9020-appx-r.html#d0e356598">37 CFR
                              41.37(c)</a></b>. However, for applications in which the appeal brief was
                        filed on or after March 19, 2013, the fee required to accompany the appeal brief is set to
                        zero dollars in amended <b><a href="mpep-9020-appx-r.html#d0e356606">37 CFR 41.37(a)</a></b>, and accordingly, the
                        phrase “appeal brief in compliance with <b><a href="mpep-9020-appx-r.html#d0e356598">37 CFR 41.37</a></b>” no longer requires the
                        filing of the appeal brief fee. See <i>Setting and Adjusting Patent Fees,</i>
                        78 Fed. Reg. 4212, 4291 (January 18, 2013).
                     </p>
                     <p id="d0e274198"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(a)(5)</a></b> pertains to the provisions of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(A)(iii)</a></b> and specifies that the period is the number of
                        days, if any, beginning on the day after the date that is four months after the date of a
                        final decision by the Patent Trial and Appeal Board (Board) or by a Federal court in an
                        appeal under <b><a href="mpep-9015-appx-l.html#d0e303314">35 U.S.C. 141</a></b> or a civil action under
                        <b><a href="mpep-9015-appx-l.html#d0e303379">35
                              U.S.C. 145</a></b> or <b><a href="mpep-9015-appx-l.html#d0e303393">146</a></b>, where at least one allowable claim
                        remains in the application and ending on the mailing date of either an action under
                        <b><a href="mpep-9015-appx-l.html#d0e303187">35
                              U.S.C. 132</a></b>, or a notice of allowance under <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C.
                              151</a></b>, whichever occurs first. 
                     </p>
                     <p id="d0e274222"> The phrase “allowable claims remain in
                        the application” for purposes of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C. 154(b)(1)(A)(iii)</a></b> means that
                        after the decision there is at least one pending claim (for purposes of statutory
                        construction, “words importing the plural include the singular” (<b><a href="mpep-9015-appx-l.html#d0e300800">1 U.S.C.
                              1</a></b>)) that is not withdrawn from consideration and is not subject to a
                        rejection, objection, or other requirement. This applies in the following situations: (1)
                        at least one claim is allowable (not merely objected to) at the time the examiner’s answer
                        is mailed and is not canceled before, or made subject to a rejection as a result of, the
                        appellate review; or (2) when all of the rejections applied to at least one claim are
                        reversed, and such claim is not made subject to a rejection, as a result of the appellate
                        review. For example: 
                     </p>
                     <div id="d0e274231" class="List">
                        <ul style="list-style-type: none;">
                           <li id="d0e274232" class="nobull">(A) If claims 1 and 2 (both
                              independent) are pending, the decision affirms the rejection of claim 1, and claim
                              2 was indicated as allowable prior to the appeal, then “allowable claims remain in
                              the application” for purposes of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                                    154(b)(1)(A)(iii)</a></b>. 
                           </li>
                           <li id="d0e274239" class="nobull">(B) If claims 1 and 2 are pending,
                              the decision affirms the rejection of claim 1, and claim 2 was objected to by the
                              examiner prior to the appeal as being allowable except for its dependency from
                              claim 1, “allowable claims” do not “remain in the application” for purposes of
                              <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C. 154(b)(1)(A)(iii)</a></b>
                              (claim 2 is not allowable because there is an outstanding objection to it).
                              
                           </li>
                           <li id="d0e274246" class="nobull">(C) If claims 1 and 2 are pending
                              (claim 2 either depending from claim 1 or is an independent claim), and the
                              decision affirms the rejection of claim 1 and reverses the rejection of claim 2,
                              then “allowable claims remain in the application” for purposes of
                              <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C. 154(b)(1)(A)(iii)</a></b>
                              (claim 2 is “allowable” within the meaning of <b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                                    1.703(a)(5)</a></b>) because there is no outstanding objection or
                              requirement as to it (see <b><a href="s1214.html#d0e129362">MPEP § 1214.06</a></b>, paragraph (II)).
                              
                           </li>
                        </ul>
                     </div>
                     <p id="ch2700_d222f1_1b09f_1a4">For a Board decision to
                        be a ‘‘decision by the Patent Trial and Appeal Board under <b><a href="mpep-9015-appx-l.html#d0e303218912313">[35 U.S.C.]
                              134</a></b>’’ within the meaning of <b><a href="mpep-9015-appx-l.html#d0e303571">35 U.S.C. 154(b)(1)(A)(iii)</a></b> (and
                        <b><a href="mpep-9020-appx-r.html#eff_20130401_d0e331390">§
                              1.703(a)(5)</a></b>), the decision must sustain or reverse the rejection(s)
                        of the claim(s) on appeal, or in limited circumstances as further described below, a remand
                        may be deemed a decision for purposes of <b><a href="mpep-9020-appx-r.html#eff_20130401_d0e331390">37 CFR
                              1.703(a)(5)</a></b>. For a Board decision to be a ‘‘decision by the Patent
                        Trial and Appeal Board under <b><a href="mpep-9015-appx-l.html#al_d1fbe1_19834_19b">[35 U.S.C.] 135</a></b>’’within the meaning of
                        <b><a href="mpep-9015-appx-l.html#d0e303571">35 U.S.C.
                              154(b)(1)(A)(iii)</a></b> (and <b><a href="mpep-9020-appx-r.html#eff_20130401_d0e331390">§
                              1.703(a)(5)</a></b>), the decision must include a decision on the
                        patentability of the claims, derivation or priority of invention. 
                     </p>
                     <p id="ch2700_d1ff72_1b9cf_20b">If an application is remanded by a panel and the
                        remand is the last action by a panel of the Board prior to the mailing of a notice of
                        allowance under <b><a href="mpep-9015-appx-l.html#d0e303440">35
                              U.S.C. 151</a></b>, the remand generally shall be considered a decision by
                        the Patent Trial and Appeal Board as that phrase is used in <b><a href="mpep-9015-appx-l.html#d0e303571">35 U.S.C.
                              154(b)(1)(A)(iii)</a></b>, a decision in the review reversing an adverse
                        determination of patentability as that phrase is used in <b><a href="mpep-9015-appx-l.html#d0e303640">35 U.S.C.
                              154(b)(1)(C)(iii)</a></b>, and a final decision in favor of the applicant as
                        that phrase is used in <b><a href="mpep-9020-appx-r.html#eff_20130401_d0e331549">37 CFR 1.703(e)</a></b>. However, a remand by a
                        panel of the Board shall not be considered a decision in the review reversing an adverse
                        determination of patentability, as provided in this paragraph, if there is filed a request
                        for continued examination under <b><a href="mpep-9015-appx-l.html#d0e303196">35 U.S.C. 132(b)</a></b> that was not first
                        preceded by the mailing, after the remand, of at least one of an action under
                        <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C.
                              132</a></b> or a notice of allowance under <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C.
                              151</a></b>.
                     </p>
                     <p id="ch2700_d1ff72_1bacc_3a5">The phrase ‘‘final decision’’ in
                        <b><a href="mpep-9020-appx-r.html#eff_20130401_d0e331390">37
                              CFR 1.703(a)(5)</a></b> means that: (1) the decision is the last decision in
                        the review by the Board (or by a Federal court); and (2) the decision does not require
                        further action by the applicant to avoid termination of proceedings as to the rejected
                        claims. Thus, a Board decision containing a new ground of rejection under <b><a href="mpep-9020-appx-r.html#d0e357030">37 CFR
                              41.50(b)</a></b> requires action by the applicant to avoid termination of
                        proceedings as to the rejected claim s and is, thus, is not considered a ‘‘final decision’’
                        for purposes of <b><a href="mpep-9020-appx-r.html#eff_20130401_d0e331390">37 CFR 1.703(a)(5)</a></b>. The phrase ‘‘final
                        decision,’’ however, does not require that the decision be final for purposes of judicial
                        review (<i>e.g.</i>, a Board decision reversing the rejection of all of the
                        claims on appeal is not ‘‘final’’ for purposes of judicial review, but (absent a subsequent
                        decision by the Board) is a ‘‘final decision’’ for purposes of 37 <b><a href="mpep-9020-appx-r.html#eff_20130401_d0e331390">37 CFR
                              1.703(a)(5)</a></b>).
                     </p>
                     <p id="d0e274259"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(a)(6)</a></b> pertains to the provisions of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(A)(iv)</a></b> and specifies that the period is the number of days,
                        if any, beginning on the day after the date that is four months after the date the issue
                        fee was paid and all outstanding requirements were satisfied and ending on the date the
                        patent was issued. The date the issue fee was paid and all outstanding requirements were
                        satisfied is the later of the date the issue fee was paid or the date all outstanding
                        requirements were satisfied. Note that the filing of a priority document (and processing
                        fee) is not considered an outstanding requirement under <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(A)(iv)</a></b> and <b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR 1.703(a)(6)</a></b>
                        because if the priority document is not filed the patent simply issues without the priority
                        claim (the application is not abandoned). If prosecution in an application is reopened
                        after allowance (see <b><a href="s1308.html#d0e133618">MPEP § 1308</a></b>), all outstanding requirements
                        are not satisfied until the application is again in condition for allowance as indicated by
                        the issuance of a new notice of allowance under <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C. 151</a></b> (see
                        <b><a href="s1308.html#d0e133618">MPEP §
                              1308</a></b>) and the form PTOL-85(b) from the latest notice of allowance
                        is returned to the Office along with any outstanding requirements, such as payment of any
                        additional fees owed and/or additional required drawings to be submitted by the
                        applicant.
                     </p>
                     <p id="d0e274283"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(b)</a></b> pertains to the provisions of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(B)</a></b> and indicates that the period of adjustment under
                        <b><a href="mpep-9020-appx-r.html#d0e331127">37
                              CFR 1.702(b)</a></b> is the number of days, if any, in the period beginning
                        on the day after the date that is three years after the actual filing date of the
                        application and ending on the date a patent was issued. <b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR 1.703(b)</a></b> also
                        sets forth the limitations on patent term adjustment specified in <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(B)(i) and (ii)</a></b>. Specifically, <b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(b)</a></b> provides that the period of adjustment of the term of a
                        patent shall not include the period equal to&nbsp;the sum of the following periods: (1) The
                        period of&nbsp;pendency consumed by continued examination of&nbsp;the application under
                        <b><a href="mpep-9015-appx-l.html#d0e303187">35
                              U.S.C. 132(b)</a></b> (<b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.&nbsp;154(b)(1)(B)(i)</a></b>); (2) the
                        period of pendency consumed by interference proceedings (<b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(B)(ii)</a></b>); (3) the period of pendency consumed by imposition
                        of a secrecy order (<b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C. 154(b)(1)(B)(ii)</a></b>); and (4)
                        the period of pendency consumed by appellate review under <b><a href="mpep-9015-appx-l.html#d0e303218">35 U.S.C.
                              134</a></b>, <b><a href="mpep-9015-appx-l.html#d0e303314">141</a></b>, <b><a href="mpep-9015-appx-l.html#d0e303379">145</a></b>,
                        whether successful or unsuccessful (<b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C. 154(b)(1)(B)(ii)</a></b>). The
                        provisions of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C. 154(b)(1)(B)(iii)</a></b> concerning
                        the period of pendency consumed by delays in the processing of the application requested by
                        the applicant are treated in <b><a href="mpep-9020-appx-r.html#d0e331597">37 CFR 1.704</a></b> as such applicant delays
                        are also circumstances constituting a failure of an applicant to engage in reasonable
                        efforts to conclude processing or examination of an application. 
                     </p>
                     <p id="d0e274334"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(c)</a></b> pertains to the provisions of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(C)(i)</a></b> and indicates that the period of adjustment under
                        <b><a href="mpep-9020-appx-r.html#d0e331127">37
                              CFR 1.702(c)</a></b> is the sum of the following periods (to the extent that
                        such periods are not overlapping): (1) the number of days, if any, in the period beginning
                        on the date an interference or derivation proceeding was instituted to involve the
                        application in the interference or deviation proceeding and ending on the date that the
                        interference or deviation proceeding was terminated with respect to the application; and
                        (2) the number of days, if any, in the period beginning on the date prosecution in the
                        application was suspended by the Office due to interference or derivation proceedings under
                        <b><a href="mpep-9015-appx-l.html#d0e303239">35
                              U.S.C. 135(a)</a></b> not involving the application and ending on the date of
                        the termination of the suspension.
                     </p>
                     <p id="d0e274349"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(d)</a></b> pertains to the provisions of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(C)(ii)</a></b> and indicates that the period of adjustment under
                        <b><a href="mpep-9020-appx-r.html#d0e331127">37
                              CFR 1.702(d)</a></b> is the sum of the following periods (to the extent that
                        such periods are not overlapping): (1) the number of days, if any, the application was
                        maintained in a sealed condition under <b><a href="mpep-9015-appx-l.html#d0e304551">35 U.S.C. 181</a></b>; (2) the number of days,
                        if any, in the period beginning on the date of mailing of an examiner’s answer under
                        <b><a href="mpep-9020-appx-r.html#d0e356741">37 CFR
                              41.39</a></b> in the application under secrecy order and ending on the date
                        the secrecy order was removed; (3) the number of days, if any, in the period beginning on
                        the date applicant was notified that an interference or derivation proceeding under
                        <b><a href="mpep-9015-appx-l.html#d0e303244">35 U.S.C.
                              135(a)</a></b> would be instituted but for the secrecy order and ending on
                        the date the secrecy order was removed; and (4) the number of days, if any, in the period
                        beginning on the date of notification under <b><a href="mpep-9020-appx-r.html#d0e337205">37 CFR 5.3(c)</a></b> and
                        ending on the date of mailing of the notice of allowance under <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C.
                              151</a></b> and <b><a href="mpep-9020-appx-r.html#d0e326268">37 CFR 1.311</a></b>.
                     </p>
                     <p id="d0e274376"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(e)</a></b> pertains to the provisions of <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(1)(C)(iii)</a></b> and indicates that the period of adjustment under
                        <b><a href="mpep-9020-appx-r.html#d0e331127">37
                              CFR 1.702(e)</a></b> is the sum of the number of days, if any, in the period
                        beginning on the date on which a jurisdiction over the application passes to the Patent
                        Trial and Appeal Board under <b><a href="mpep-9020-appx-r.html#d0e356583">37 CFR 41.35(a)</a></b> and ending on the date
                        of a final decision in favor of the applicant by the Board or by a Federal court in an
                        appeal under <b><a href="mpep-9015-appx-l.html#d0e303314">35 U.S.C. 141</a></b> or a civil action under
                        <b><a href="mpep-9015-appx-l.html#d0e303379">35
                              U.S.C. 145</a></b>.
                     </p>
                     <p id="d0e274400"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR 1.703(f)</a></b>
                        indicates that the adjustment will run from the expiration date of the patent as set forth
                        in <b><a href="mpep-9015-appx-l.html#d0e303482">35
                              U.S.C. 154(a)(2)</a></b> and also indicates that to the extent that periods
                        of delay attributable to the grounds specified in <b><a href="mpep-9020-appx-r.html#d0e331127">37 CFR 1.702</a></b> overlap,
                        the period of adjustment will not exceed the actual number of days the issuance of the
                        patent was delayed (<b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C. 154(b)(2)(A)</a></b>).
                        <b><a href="mpep-9015-appx-l.html#d0e303648">35 U.S.C.
                              154(b)(2)(A)</a></b> provides that "[t]o the extent that periods of delay
                        attributable to grounds specified in [<b><a href="mpep-9015-appx-l.html#d0e303529">35 U.S.C. 154(b)(1)</a></b>] overlap, the
                        period of any adjustment granted under this subsection shall not exceed the actual number
                        of days the issuance of the patent was delayed." The USPTO previously had interpreted this
                        provision as covering situations in which a delay by the USPTO contributes to multiple
                        bases for adjustment (the "pre-Wyeth" interpretation of <b><a href="mpep-9015-appx-l.html#d0e303648">35 U.S.C.
                              154(b)(2)(A)</a></b>). See <i>Explanation of <b><a href="mpep-9020-appx-r.html#eff_20130401_d0e331568">37 CFR
                                 1.703(f)</a></b> and of the United States Patent and Trademark Office
                           Interpretation of <b><a href="mpep-9015-appx-l.html#d0e303648">35 U.S.C. 154(b)(2)(A)</a></b>,</i> 69
                        Fed. Reg. 34283 (June 21, 2004), 1284 Off. Gaz. Pat. Office 56 (July 13, 2004). The United
                        States Court of Appeals for the Federal Circuit, however, held that the USPTO's earlier
                        interpretation of <b><a href="mpep-9015-appx-l.html#d0e303648">35 U.S.C. 154(b)(2)(A)</a></b> was erroneous, and that periods of delay
                        overlap under <b><a href="mpep-9015-appx-l.html#d0e303648">35
                              U.S.C. 154(b)(2)(A)</a></b> only if the periods which measure the amount of
                        adjustment under <b><a href="mpep-9015-appx-l.html#d0e303529">35 U.S.C. 154(b)(1)</a></b> occur on the same calendar day. See
                        <i>Wyeth v. Kappos</i>, 591 F.3d 1364, 93 USPQ2d 1257 (Fed. Cir. 2010). 
                     </p>
                     <p id="ch2700_d1ff72_20dcb_32b"><b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(f)</a></b> also specifically indicates that the term of a patent
                        entitled to adjustment under <b><a href="mpep-9020-appx-r.html#d0e331127">37 CFR 1.702</a></b> and <b><a href="mpep-9020-appx-r.html#d0e331320">1.703</a></b> shall be adjusted for the sum of the periods calculated under
                        <b><a href="mpep-9020-appx-r.html#d0e331320">37
                              CFR 1.703(a) through (e)</a></b>, to the extent that such periods are not
                        overlapping, less the sum of the periods calculated under <b><a href="mpep-9020-appx-r.html#d0e331597">37 CFR
                              1.704</a></b>. 
                     </p>
                     <p id="d0e274435"> Moreover, <b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(f)</a></b> provides that the date indicated on any certificate of
                        mailing or transmission under <b><a href="mpep-9020-appx-r.html#d0e313726">37 CFR 1.8</a></b> shall not be taken into
                        account in this calculation. The date indicated on a certificate of mailing is used only to
                        determine whether the correspondence is timely (including whether any extension of the time
                        and fee are required) so as to avoid abandonment of the application or termination or
                        dismissal of proceedings. The actual date of receipt of the correspondence in the Office is
                        used for all other purposes. See <b><a href="mpep-9020-appx-r.html#d0e313726">37 CFR 1.8(a)</a></b>. Thus, while the date
                        indicated on any certificate of mailing or transmission under <b><a href="mpep-9020-appx-r.html#d0e313726">37 CFR
                              1.8</a></b> will continue to be taken into account in determining timeliness,
                        the date of filing (<b><a href="mpep-9020-appx-r.html#d0e313447">37 CFR 1.6</a></b>) will be the date used in a
                        patent term adjustment calculation. Applicant may wish to consider the use of the
                        electronic filing system (EFS), the “Express Mail Post Office to Addressee” service of the
                        United States Postal Service (<b><a href="mpep-9020-appx-r.html#d0e313951">37 CFR 1.10</a></b>) or facsimile transmission
                        (<b><a href="mpep-9020-appx-r.html#d0e313447">37
                              CFR 1.6(d)</a></b>), when permitted, for replies to be accorded the earliest
                        possible filing date for patent term adjustment calculations. Alternatively, applicant may
                        choose to mail correspondence with sufficient time to ensure that the correspondence is
                        received in the Office (and stamped with a date of receipt) before the expiration of the
                        three-month period. Applicants are encouraged to check PAIR to verify the date of deposit
                        entered in PALM for the correspondence. Applicants should contact the Office for correction
                        of any such entries prior to thegrant of the patent. At the time of the grant of the
                        patent, the patent term adjustment calculation will be made with the dates in PALM.
                        Thereafter, a patent term adjustment accompanied by the requisite fee and statement or
                        showing, will be necessary to have any reduction of patent term under <b><a href="mpep-9020-appx-r.html#eff_20130401_d0e331597">37 CFR
                              1.704</a></b> reinstated.
                     </p>
                     <p id="d0e274466"> Finally, <b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR
                              1.703(g)</a></b> indicates that no patent, the term of which has been
                        disclaimed beyond a specified date, shall be adjusted under <b><a href="mpep-9020-appx-r.html#d0e331127">37 CFR
                              1.702</a></b> and <b><a href="mpep-9020-appx-r.html#d0e331320">1.703</a></b> beyond the expiration date
                        specified in the disclaimer (<b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154(b)(2)(B)</a></b>).
                     </p>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title">&nbsp;</h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s2701.html">2701-Patent Term</a></li>
               <li xmlns=""><a href="s2702-2709.html">2702-2709-[Reserved]</a></li>
               <li xmlns=""><a href="s2710.html">2710-Term Extensions or Adjustments for Delays Within the USPTO Under 35 U.S.C. 154</a></li>
               <li xmlns=""><a href="s2711-2719.html">2711-2719-[Reserved]</a></li>
               <li xmlns=""><a href="s2720.html">2720-Applications Filed Between June 8, 1995, and May 28, 2000</a></li>
               <li xmlns=""><a href="s2721-2729.html">2721-2729-[Reserved]</a></li>
               <li xmlns=""><a href="s2730.html">2730-Applications Filed on or After May 29, 2000; Grounds for Adjustment</a></li>
               <li xmlns=""><a href="s2731.html">2731-Period of Adjustment</a></li>
               <li xmlns=""><a href="s2732.html">2732-Reduction of Period of Adjustment of Patent Term</a></li>
               <li xmlns=""><a href="s2733.html">2733-Patent Term Adjustment Determination</a></li>
               <li xmlns=""><a href="s2734.html">2734-Application for Patent Term Adjustment; Due Care Showing</a></li>
               <li xmlns=""><a href="s2735.html">2735-[Reserved]</a></li>
               <li xmlns=""><a href="s2736.html">2736-Third Party Papers</a></li>
               <li xmlns=""><a href="s2737-2749.html">2737-2749-[Reserved]</a></li>
               <li xmlns=""><a href="s2750.html">2750-Patent Term Extension for Delays at other Agencies under 35 U.S.C. 156</a></li>
               <li xmlns=""><a href="s2751.html">2751-Eligibility Requirements</a></li>
               <li xmlns=""><a href="s2752.html">2752-Patent Term Extension Applicant</a></li>
               <li xmlns=""><a href="s2753.html">2753-Application Contents</a></li>
               <li xmlns=""><a href="s2754.html">2754-Filing Date</a><ul>
                     <li><a href="s2754.html#d0e276883">2754.01-Deadline for Filing an Application Under 35 U.S.C. 156(d)(1)</a></li>
                     <li><a href="s2754.html#d0e276901">2754.02-Filing Window for an Application Under 35 U.S.C. 156(d)(5)</a></li>
                     <li><a href="s2754.html#d0e276937">2754.03-Filing of a Request for an Extension Under 35 U.S.C. 156(e)(2)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2755.html">2755-Eligibility Determination</a><ul>
                     <li><a href="s2755.html#d0e276994">2755.01-Interim Extension of Patent Term During the Processing of the Application</a></li>
                     <li><a href="s2755.html#d0e277100">2755.02-Interim Extension of Patent Term Before Product Approval</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2756.html">2756-Correspondence Between the USPTO and the Regulatory Agency</a></li>
               <li xmlns=""><a href="s2757.html">2757-Regulatory Agency Determination of the Length of the Regulatory Review Period</a><ul>
                     <li><a href="s2757.html#d0e277434">2757.01-Due Diligence Determination</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2758.html">2758-Notice of Final Determination - Calculation of Patent Term Extension</a></li>
               <li xmlns=""><a href="s2759.html">2759-Certificate of Extension of Patent Term</a></li>
               <li xmlns=""><a href="s2760.html">2760-Trade Secret, Confidential, and Protective Order Material</a></li>
               <li xmlns=""><a href="s2761.html">2761-Multiple Applications for Extension of Term of the Same Patent or of Different Patents for the Same Regulatory Review Period
                     for a Product</a></li>
               <li xmlns=""><a href="s2762.html">2762-Duty of Disclosure in Patent Term Extension Proceedings</a></li>
               <li xmlns=""><a href="s2763.html">2763-Limitation of Third Party Participation</a></li>
               <li xmlns=""><a href="s2764.html">2764-Express Withdrawal of Application for Extension of Patent Term</a></li>
            </ul>  </div>
         </div>
      </div>  </div>
      <!-- Footer Navigation: /includes/general/footer2.html -->

<!-- Used in: MPEP, CPC -->

<!-- ID = $Id: footer2.html 3354 2013-04-23 18:43:33Z janaki $ -->

<!-- URL = $URL: https://dev-wmb-svn.etc.uspto.gov/repos/live/active_content/trunk/includes/general/footer2.html $ -->





  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:35 

  </div>

</div>

</div>




<!-- End of footer2.html -->


   </body>
</html>